Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cytogen Corporation (NasdaqNM:CYTO)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug  7Earnings Announcement
Location
600 College Road East, CN 5308
Princeton, NJ 08540
Phone: (609) 750-8200
Fax: (609) 452-2975
Email: cytoinfo@corpcomm.cytogen.com
Employees (last reported count): 77
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 8%
·Over the last 6 months:
 · 2 insider sells; 22.0K shares
  (0.3% of insider shares)
·Institutional: 16% (18% of float)
(91 institutions)
·Net Inst. Buying: 2.54M shares (+16.49%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cytogen Corporation is a biopharmaceutical company with two principal lines of business, proteomics and oncology. The Company is extending its expertise in antibodies and molecular recognition to the development of new products and a proteomics-driven drug discovery platform. The Company has established a pipeline of product candidates based upon its proprietary antibody and its exclusively licensed prostate specific membrane antigen (PSMA) technologies. The Company is also developing a proprietary protein pathway database as a drug discovery and development tool for the pharmaceutical and biotechnology industries.
More from Market Guide: Expanded Business Description

Financial Summary
CYTO is a biopharmaceutical company with two principal lines of business, proteomics and oncology. The Company also develops products for antibodies and molecular recognition. For the six months ended 6/30/01, total revenues rose 15% to $5.8 million. Net loss before acct. change rose 39% to $5.7 million. Results reflect the release of new products and the establishment of an in-house oncology sales force, offset by increased development costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

James Grigsby, 58
Chairman
--  --  
H. Joseph Reiser, Ph.D., 54
Pres, CEO, Director
$606K$1.0M
Lawrence Hoffman, 46
VP, CFO
131K--  
Catherine Verna, 36
VP, Gen. Counsel, Sec.
--  --  
Deborah Kaminsky
VP of Sales and Marketing
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CYTOAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$2.00 
Recent Price$3.55 
52-Week High
on 1-Sep-2000
$9.188
Beta1.13 
Daily Volume (3-month avg)243.5K
Daily Volume (10-day avg)144.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-60.3%
52-Week Change
relative to S&P500
-46.7%
Share-Related Items
Market Capitalization$281.7M
Shares Outstanding79.4M
Float73.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.20 
Earnings (ttm)-$0.33 
Earnings (mrq)-$0.04 
Sales (ttm)$0.15 
Cash (mrq)$0.24 
Valuation Ratios
Price/Book (mrq)17.36 
Price/EarningsN/A 
Price/Sales (ttm)24.00 
Income Statements
Sales (ttm)$11.2M
EBITDA (ttm)-$26.6M
Income available to common (ttm)-$24.6M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-113.33%
Return on Equity (ttm)-213.04%
Financial Strength
Current Ratio (mrq)3.50 
Debt/Equity (mrq)0.15 
Total Cash (mrq)$18.7M
Short Interest
As of 8-Aug-2001
Shares Short136.0K
Percent of Float0.2%
Shares Short
(Prior Month)
187.0K
Short Ratio0.76 
Daily Volume179.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.